Patients with severe to profound outer retinal degeneration will be able to access the Argus II Retinal Prosthesis System following its approval by Health Canada.
Developed by Second Sight Medical Products, the Argus II has been implanted in more than 100 individuals worldwide and is the first approved retinal prosthesis in the world. It is the only retinal prosthesis approved by Health Canada and the U.S. Food and Drug Administration (FDA). It is approved for use in the European Economic Area (CE Mark) and is available in some European countries.
Argus II induces visual perception in blind patients with electrical pulses to stimulate the retina’s remaining cells, which results in perceptions of light patterns in the brain.
